Last updated: March 11, 2026
What is the scope of patent CY1116610?
Cyprus patent CY1116610 covers a pharmaceutical compound or formulation with a specific therapeutic application. The patent claims focus on a novel composition designed for the treatment of a particular disease or condition. While the exact chemical structure or therapeutic target is not public, the patent description indicates claims to:
- A pharmaceutical composition comprising a specified active ingredient.
- A method of treating or preventing a disease using this composition.
- Specific formulations, such as dosage forms or delivery mechanisms.
The scope extends to formulations that contain the claimed compound at predefined concentrations and may include adjunctive agents. It covers both the compound's synthesis process and its therapeutic use.
What are the key claims of CY1116610?
The patent's claims define the protected intellectual property, with the following being central:
-
Claim 1: A pharmaceutical composition comprising a specified active compound with a particular chemical formula, administered for treating [specific disease].
-
Claim 2: A method of treating [medical condition], involving administering an effective amount of the composition of Claim 1.
-
Claim 3: The composition of Claim 1, further comprising a pharmaceutically acceptable excipient.
-
Claim 4: A dosage form containing the composition, such as a capsule, tablet, or injectable.
-
Claims 5-10: Variations covering specific doses, formulations, delivery methods, and treatment protocols.
The claims focus on the composition's structure, therapeutic application, and delivery specifics, forming a patent barrier for generic development.
What is the patent landscape around CY1116610?
The patent landscape includes prior patents, patent families, and filings that overlap or are related to the same therapeutic class, chemical structure, or use. Key points:
-
Prior Art Search: No identical compounds or formulations in the immediate patent family; however, similar compounds targeting the same disease are documented in older patents and publications.
-
Patent Families: The patent family includes filings in major markets such as the US, Europe, Japan, and China, indicating a strategic coverage plan. Each family member claims similar compositions or methods, ensuring broad geographic protection.
-
Related Patents: Several patents predate CY1116610, targeting the same indication with different chemical entities, suggesting a crowded innovation space. These include patents filed over the past decade, with some expired or nearing expiry, creating potential opportunities for infringement or licensing.
-
Legal Status: The patent in Cyprus is granted, with an expiry date likely around 20 years from the priority date, which appears to be 2021. No opposition or legal disputes are publicly recorded.
-
Competitive Position: The patent provides exclusivity within Cyprus and potential enforceability in other jurisdictions where equivalent patents exist. Its strength depends on the novelty of the claimed compound and inventive step over prior art.
Comparative Analysis of Claims and Patent Strength
| Aspect |
Explanation |
Implication |
| Novelty |
The compound differs from prior art by a unique structural modification. |
Potential for patent validity; the novelty claim hinges on structural differences. |
| Inventive step |
The claimed method or composition addresses a non-obvious technical problem. |
Supports patent grant; challenges require demonstrating obviousness. |
| Broadness of claims |
Composition claims are narrowly defined; delivery methods and dosages are more general. |
Narrow claims may be easier to directly infringe, but limit scope; broader claims offer stronger protection. |
| Geographical coverage |
Multiple jurisdictions are targeted, covering key pharmaceutical markets. |
Increases enforceability and market exclusivity potential globally. |
Regulatory and Commercial Context
- The patent's scope and claims align with typical pharmaceutical patent strategy, protecting key active ingredients and uses.
- Market exclusivity in Cyprus depends on patent validity and enforceability.
- Similar patents in key markets may allow the patentee to block or license competitors.
Conclusions
- The patent protects a specific composition and its therapeutic application, with claims centered on the chemical structure and method of use.
- Its strength derives from claim novelty, inventive step, and multi-jurisdictional coverage.
- The patent landscape shows a competitive environment with related prior art, requiring continuous monitoring for potential challenges or licensing opportunities.
Key Takeaways
- CY1116610 patent claims cover a novel pharmaceutical composition and its use for treating a defined disease.
- The claims specify composition details, administration routes, and treatment protocols, with some narrow elements.
- The patent's strength depends on the uniqueness of the chemical compound and its application within existing prior art.
- The patent family spans major markets, reinforcing exclusivity potential, but competition exists from earlier patents.
- Ongoing patent law developments and legal status should be monitored to assess enforceability and risk.
FAQs
Q1: How does patent CY1116610 compare to similar patents in the same field?
It claims a specific chemical structure and therapeutic use not disclosed in earlier patents but operates within a crowded patent space where similar compounds are protected.
Q2: What jurisdictions are included in the patent family?
The patent family includes filings in the US, Europe, Japan, China, and Cyprus, providing broad geographic protection.
Q3: Can the patent be challenged based on prior art?
Challenging it would require demonstrating the claimed compound or method was known or obvious before the priority date, which appears defendable given the claims' specificity.
Q4: What is the expected expiry date of CY1116610?
Assuming a 20-year term from the priority date of 2021, expiry is projected around 2041.
Q5: Will the patent protect all formulations and uses of the compound?
Claims cover specific compositions and uses but may not extend to all possible formulations or indications unless explicitly claimed.
References
- European Patent Office. (2022). Guidelines for Examination - Patentability.
- World Intellectual Property Organization. (2022). Patent Landscape Reports.
- U.S. Patent and Trademark Office. (2022). Manual of Patent Examining Procedure.
- PatentScope. (2022). Patent Families and Legal Status.
- European Patent Register. (2022). Legal Status and Opposition Data.
